Study of the Effect of Interaction between Traumatic Brain Injury and Functional Polymorphisms of Interleukin Genes on the Severity of Schizophrenia

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The aim of the study was to assess the associations between TBI and symptom severity in patients with schizophrenia, taking into account the modulating influence of polymorphisms of pro- and anti-inflammatory interleukins genes. The study included 1157 patients with schizophrenia (ICD-10 items F20, F21, F23.1, F25.). 452 patients had a history of TBI, 538 patients denied TBI. The severity of schizophrenia symptoms was measured using the PANSS. Three polymorphisms located in the promoters of the genes encoding interleukins IL-4 (C-589T) rs2243250 and IL-10 (C-592A) rs1800872 were selected for the genetic study. A mutual effect of TBI and the interleukin gene variants IL-4 (C-589T) rs2243250 and IL-10 (C-592A) rs1800872 on the severity of schizophrenia symptoms was found. In particular, in the group of CC IL-4 (C-589T) genotype carriers, the severity of negative and general psychopathological symptoms was higher than in carriers of the T allele. The IL-10 (C-592A) rs1800872 polymorphism modified the effect of TBI on general psychopathological, but not positive or negative symptoms of schizophrenia. The severity of these symptoms was higher in carriers of the CC genotype compared to carriers of the A allele. In patients without TBI, the polymorphisms did not have a significant effect on the phenotype. Thus, our study has shown for the first time that the presence of a history of TBI and the patient's genetic characteristics negatively affect the severity of schizophrenia.

Texto integral

Acesso é fechado

Sobre autores

T. Lezheiko

Scientific Center for Mental Health

Autor responsável pela correspondência
Email: lezheiko@list.ru
Rússia, Moscow, 115522

M. Gabaeva

Scientific Center for Mental Health

Email: lezheiko@list.ru
Rússia, Moscow, 115522

S. Koroleva

Scientific Center for Mental Health

Email: lezheiko@list.ru
Rússia, Moscow, 115522

N. Kolesina

Scientific Center for Mental Health

Email: lezheiko@list.ru
Rússia, Moscow, 115522

V. Golimbet

Scientific Center for Mental Health

Email: lezheiko@list.ru
Rússia, Moscow, 115522

Bibliografia

  1. Robinson N., Bergen S.E. Environmental risk factors for schizophrenia and bipolar disorder and their relationship to genetic risk: Current knowledge and future directions // Front. Genet. 2021. V. 12. https://doi.org/10.3389/fgene.2021.686666
  2. Kim E. Does traumatic brain injury predispose individuals to develop schizophrenia? // Curr. Op. in Psychiatry. 2008. V. 21(3). P. 286–289. https://doi.org/10.1097/YCO.0b013e3282fbcd21
  3. Nkemjika S., Olayinka O., Atolagbe A. et al. Traumatic brain Injury related schizophrenia in individuals without family history: A case series // J. Natl Med. Ass. 2022. V. 114(2). P. 207–210. https://doi.org/10.1016/j.jnma.2022.01
  4. Molloy C., Conroy R.M., Cotter D.R. et al. Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies // Schizophrenia Bull. 2011. V. 37(6). P. 1104–1110. https://doi.org/10.1093/schbul/sbr091
  5. Silvestro S., Raffaele I., Quartarone A. et al. Innovative insights into traumatic brain injuries: Biomarkers and new pharmacological targets // Int. J. Mol. Sci. 2024. V. 25(4). https://doi.org/10.3390/ijms25042372
  6. Mavroudis I., Ciobica A., Balmus I.M. et al. A Systematic review and meta-analysis of the inflammatory biomarkers in mild traumatic brain injury // Biomedicines. 2024. V. 12(2). https://doi.org/10.3390/biomedicines12020293
  7. Cash A., Theus M.H. Mechanisms of blood-brain barrier dysfunction in traumatic brain Injury // Int. J. Mol. Sci. 2020. V. 21(9). https://doi.org/10.3390/ijms21093344
  8. Клюшник Т.П., Смулевич А.Б., Зозуля С.А., Воронова Е.И. Нейробиология шизофрениии и клинико-психопатологические корреляты (к построению клинико-биологической модели) // Психиатрия. 2021. T. 19(1). C. 6–15. https://doi.org/ 10.30629/2618-6667-2021-19-1-6-15
  9. Клюшник Т.П., Зозуля С.А., Андросова Л.В., Сарманова З.В. и др. Иммунологический мониторинг эндогенных приступообразных психозов // Журн. неврол. и психиатрии им. С.С. Корсакова. 2014. T. 114(2). C. 37–41. https://doi.org/10.31550/1727-2378-2023-22-6-7-14
  10. Dahan S., Bragazzi N.L., Yogev A. et al. The relationship between serum cytokine levels and degree of psychosis in patients with schizophrenia // Psychiatry Res. 2018. V. 268. P. 467–472. https://doi.org/10.1016/j.psychres.2018.07.041
  11. Yan F., Meng X., Cheng X. et al. Potential role between inflammatory cytokines and Tie-2 receptor levels and clinical symptoms in patients with first-episode schizophrenia // BMC Psychiatry. 2023. V. 25 (1). P. 538. https://doi.org/10.1186/s12888-023-04913-7
  12. Zhilyaeva T.V., Rukavishnikov G.V., Manakova E.A. et al. Serum interleukin-6 in schizophrenia: Associations with clinical and sociodemographic characteristics // Consort. Psychiatria. 2023. V. 22(4). P. 5–16. https://doi.org/10.17816/CP11067
  13. Ельчанинова Е.Ю., Афанасьева А.И., Смагина И.В., Ельчанинова С.А. Черепно-мозговая травма до дебюта рассеянного склероза: связь с прогрессированием неврологических расстройств и патобиохимическими показателями цереброспинальной жидкости // Журн. неврол. и психиатрии им. С.С. Корсакова. 2023. T. 123(7–2). C. 72–76. https://doi.org/10.17116/jnevro202312307272
  14. Rosenwasser L.J., Borish L. Genetics of atopy and asthma: The rationale behind promoter-based candidate gene studies (IL-4 and IL-10) // Am. J. Respiratory and Critical Care Med. 1997. V. 156(4–2). P. 152–155. https://doi.org/10.1164/ajrccm.156.4.12tac-14
  15. Pu H., Zheng X., Jiang X. et al. Interleukin-4 improves white matter integrity and functional recovery after murine traumatic brain injury via oligodendroglial PPARγ // J. Cerebral Blood Flow & Metabolism. 2021. V. 41(3). P. 511–529. https://doi.org/10.1177/0271678X20941393
  16. Dunleavy C., Elsworthy R.J., Upthegrove R. et al. Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis // Acta Psychiatrica Scandinavica. 2022. V. 146(1). P. 6–20. https://doi.org/10.1111/acps.13416
  17. Zhang Y.M., Zhou X.C., Xu Z. et al. Meta-analysis of epidemiological studies of association of two polymorphisms in the interleukin-10 gene promoter and colorectal cancer risk // Genet. Mol. Res. 2012. V. 11(3). P. 3389–3397. https://doi.org/10.4238/2012
  18. Crawley E., Kay R., Sillibourne J. et al. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis // Arthritis & Rheumatology. 1999. V. 42(6). P. 1101–1108. https://doi.org/10.1002/1529-0131
  19. Carlini V., Noonan D.M., Abdalalem E. et al. The multifaceted nature of IL-10: Regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions // Front. Immunol. 2023. V. 14. https://doi.org/10.3389/fimmu.2023.1161067
  20. Uzan M., Tanriverdi T., Baykara O. et al. Association between interleukin-1 beta (IL-1beta) gene polymorphism and outcome after head injury: An early report // Acta Neurochirurgica. 2005. V. 147(7). P. 715–720. https://doi.org/10.1007/s00701-005-0529

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Russian Academy of Sciences, 2025